🔗 Share this article

Chancellor Reeves has announced she is preparing "specific action to tackle cost of living pressures" in the forthcoming Budget.

In comments to media outlets, she emphasized that lowering price rises is a collective responsibility of both the government and the central bank.

The United Kingdom's price growth is projected to be the most elevated among the Group of Seven advanced economies this calendar year and next.

Potential Energy Cost Interventions

It is understood the government could take action to reduce energy bills, for instance by slashing the present 5% level of value-added tax applied on energy supplies.

An additional option is to lower some of the policy costs currently included in household expenses.

Fiscal Constraints and Analyst Predictions

The administration will receive the next draft from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much room there is for such actions.

The consensus from most economists is that Reeves will have to declare tax rises or spending cuts in order to fulfill her voluntary fiscal targets.

Earlier on the same day, estimates indicated there was a £22bn gap for the chancellor to address, which is at the lower end of expectations.

"There's a collective job between the central bank and the administration to bear down further on some of the sources of inflation," Reeves stated to the BBC in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Commitments and Global Concerns

While much of the attention has been on probable tax rises, the Treasury chief said the latest information from the OBR had not altered her pledge to manifesto promises not to increase tax levels on earnings tax, VAT or social security contributions.

She attributed an "uncertain world" with rising international and commercial issues for the Budget tax moves, probably to be targeted on those "most able to pay."

Global Economic Disputes

Addressing apprehensions about the United Kingdom's trade ties with the Asian nation she said: "The UK's national security invariably come first."

Last week's declaration by China to tighten trade restrictions on critical minerals and other materials that are essential for high-technology manufacturing led American leader the US President to propose an further 100% tariff on imports from the Asian country, increasing the risk of an full-scale trade war between the two global powers.

The American finance chief called the Chinese move "economic coercion" and "a global supply chain control attempt."

Inquired about considering the US offer to join its conflict with China, the Chancellor said she was "very concerned" by Chinese measures and urged the Chinese government "not to put up barriers and restrict access."

She said the action was "harmful for the world economy and creates further headwinds."

"It is my opinion there are sectors where we must challenge Chinese policies, but there are also valuable chances to trade with Chinese markets, including banking sector and other areas of the economy. We've got to get that equilibrium correct."

The chancellor also affirmed she was working with G7 counterparts "regarding our own essential resources strategy, so that we are more independent."

Health Service Drug Pricing and Investment

The Chancellor also admitted that the price the NHS spends on pharmaceuticals could increase as a consequence of current talks with the US government and its pharmaceutical firms, in exchange for reduced taxes and investment.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either pausing or scrapping operations in the United Kingdom, with several attributing the modest returns they are receiving.

Last month, the Science Minister said the price the health service spends on medicines would have to increase to halt firms and drug research funding departing from the UK.

Reeves told media: "We have seen due to the cost structure, that medical research, recent pharmaceuticals have not been available in the UK in the extent that they are in other European countries."

"We want to ensure that people getting treatment from the NHS are able to receive the top essential drugs in the globe. And so we are examining these issues, and... aiming to secure additional investment into Britain."